Optimizing Prescribing of Antipsychotics in Long-Term Care

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC. A multi component intervention to reduce inappropriate antipsychotic prescribing was evaluated in ten Canadian long-term care facilities.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Deprescribing Antipsychotics in Long-Term Care

NCT02958800

Dementia Behavior

COMPLETED NA

Deprescribing in a Long Term Care Facility

NCT03091153

Polypharmacy

COMPLETED NA

Deprescribing Intervention Among Nursing Home Residents With Major Neurocognitive Disorders

NCT05155748

Dementia

COMPLETED NA

Randomised, Controlled Trial of an Individual Deprescribing Intervention for Nursing Homes Residents

NCT03655405

Polypharmacy Inappropriate Prescribing

COMPLETED NA

Opportunities and Limits to Deprescribing in Nursing Homes:Quality Circle Deprescribing Module

NCT03688542

Polypharmacy Inappropriate Prescribing

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Increasing numbers of older adults are affected by dementia, and many will eventually reside in long-term care (LTC), where antipsychotic use is relatively common. Inappropriate antipsychotic prescribing is a key quality indicator by which clinical outcomes might be monitored and improved in LTC but limited evidence exists on the most effective strategies for reducing inappropriate antipsychotic use.

The objective of the study was to evaluate a multicomponent approach to reduce inappropriate prescribing of antipsychotics in LTC.

A prospective, randomized stepped-wedge, study design was used to evaluate the effect of the intervention in 10 LTC facilities in Canada. The intervention consisted of an educational in-service, provision of evidence-based tools to assess and monitor neuropsychiatric symptoms (NPS) and monthly interprofessional team meetings.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dementia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Randomized, stepped-wedge cluster trial.

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational

Multi component educational intervention in long-term care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of dementia
* Receiving an antipsychotic medication without a diagnosis of psychosis

Exclusion Criteria

* Diagnoses of schizophrenia, Huntington's disease
* Presence of active hallucinations and/or delusions
* Individuals at end of live or receiving palliative care

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No